Jones Financial Companies’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.3K Buy
597
+9
+2% +$208 ﹤0.01% 3620
2026
Q1
$11.8K Sell
588
-668
-53% -$15.1K ﹤0.01% 3522
2025
Q4
$29.8K Sell
1,256
-20
-2% -$487 ﹤0.01% 2763
2025
Q3
$30.6K Hold
1,276
﹤0.01% 2583
2025
Q2
$28.1K Buy
1,276
+166
+15% +$3.84K ﹤0.01% 2455
2025
Q1
$25.1K Buy
1,110
+707
+175% +$16.4K ﹤0.01% 2348
2024
Q4
$7.88K Sell
403
-289
-42% -$5.73K ﹤0.01% 2613
2024
Q3
$12.5K Sell
692
-278
-29% -$5.3K ﹤0.01% 2136
2024
Q2
$16.9K Buy
+970
New +$17.2K ﹤0.01% 1595

Other funds holding PRVA

Jones Financial Companies's PRVA Position: Q2 2026 in Review

Jones Financial Companies increased its Privia Health (PRVA) stake by 1.5% in Q2 2026, buying an estimated $208 and bringing the position to 597 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3620.

Jones Financial Companies first reported a position in PRVA in Q2 2024 and has held it in 9 quarters since. The position peaked at $30.6K in Q3 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Jones Financial Companies held 597 shares of Privia Health worth $15.3K as of Q2 2026.
  • Jones Financial Companies bought 9 Privia Health shares in Q2 2026, an estimated $208.
  • Privia Health made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3620 holding.
  • Jones Financial Companies first reported a position in Privia Health in Q2 2024 and has held it in 9 quarters since.
  • Jones Financial Companies's Privia Health position peaked at $30.6K in Q3 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.